CN Patent

CN105663063B — 甘草酸二铵和恩替卡韦的复方微丸片及其制备方法

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2017-12-08 · 8y expired

What this patent protects

本发明属于药物制剂领域，涉及一种甘草酸二铵和恩替卡韦的复方微丸片及其制备方法，由包覆有隔离层和肠溶缓释层的甘草酸二铵微丸和内部为空白丸芯、外部包覆恩替卡韦含药层的恩替卡韦微丸按照合理的处方比例共同压片制得，本发明得到的复方微丸片均一度高，可压性好，溶出特性优异，具有较高的临床应用前景。

USPTO Abstract

本发明属于药物制剂领域，涉及一种甘草酸二铵和恩替卡韦的复方微丸片及其制备方法，由包覆有隔离层和肠溶缓释层的甘草酸二铵微丸和内部为空白丸芯、外部包覆恩替卡韦含药层的恩替卡韦微丸按照合理的处方比例共同压片制得，本发明得到的复方微丸片均一度高，可压性好，溶出特性优异，具有较高的临床应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN105663063B
Jurisdiction
CN
Classification
—
Expires
2017-12-08
Drug substance claim
No
Drug product claim
No
Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.